-
1
المؤلفون: Els Meulemans, Clemens F. M. Prinsen, Daniëlle A.M. Heideman, Judith V.M.G. Bovée, Adriaan J. C. van den Brule, Ed Schuuring, Roel A. de Weger, K. C. Scheidel, Carel J. M. van Noesel, Petra M. Nederlof, Hans Bruinsma, Winand N.M. Dinjens, Marjolijn J. L. Ligtenberg, Peter M. van de Ven, Erik Thunnissen
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Faculteit der Geneeskunde, Pathologie, RS: GROW - School for Oncology and Reproduction, Pathology, Epidemiology and Data Science, CCA - Oncogenesis, CCA - Innovative therapy, Cancer Center Amsterdam
المصدر: Journal of Clinical Pathology, 64(10), 884-892. BMJ PUBLISHING GROUP
Journal of clinical pathology, 64(10), 884-892. BMJ Publishing Group
Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 64, 884-92
Journal of Clinical Pathology, 64(10), 884-892. BMJ Publishing Group
Journal of Clinical Pathology, 64(10), 884-892
Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 64, 10, pp. 884-92
Thunnissen, F B J M, Bovée, J V M G, Bruinsma, H, van den Brule, A J C, Dinjens, W, Heideman, D A M, Meulemans, E, Nederlof, PM, van Noesel, C, Prinsen, C F M, Scheidel-Jacobse, K, van de Ven, P M, de Weger, R, Schuuring, E & Ligtenberg, M J L 2011, ' EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy ', Journal of Clinical Pathology, vol. 64, no. 10, pp. 884-892 . https://doi.org/10.1136/jclinpath-2011-200163مصطلحات موضوعية: Pathology, Laboratory Proficiency Testing, Lung Neoplasms, Quality Assurance, Health Care, Colorectal cancer, medicine.medical_treatment, TUMOR-CELLS, DNA Mutational Analysis, IN-SITU-HYBRIDIZATION, medicine.disease_cause, Targeted therapy, COLORECTAL-CANCER, Molecular Targeted Therapy, False Negative Reactions, In Situ Hybridization, Netherlands, Observer Variation, Predictive marker, Tissue microarray, General Medicine, Immunohistochemistry, K-RAS MUTATIONS, KRAS Mutation Analysis, ErbB Receptors, CELL-LUNG-CANCER, TISSUE MICROARRAY SURVEY, KRAS, medicine.medical_specialty, SILVER-STAINED SSCP, Biology, Sensitivity and Specificity, Pathology and Forensic Medicine, Proto-Oncogene Proteins p21(ras), SDG 3 - Good Health and Well-being, Translational research [ONCOL 3], Predictive Value of Tests, Proto-Oncogene Proteins, medicine, Biomarkers, Tumor, TYROSINE KINASE INHIBITORS, Humans, EGFR Gene Amplification, False Positive Reactions, Lung cancer, neoplasms, Patient Selection, Gene Amplification, Reproducibility of Results, medicine.disease, Tissue Array Analysis, Mutation, ras Proteins, GENE COPY NUMBER, GROWTH-FACTOR-RECEPTOR
وصف الملف: application/pdf
-
2
المؤلفون: Jan B. Vermorken, Els Meulemans, Geert De Kerf, Carl Van Laer, Yasmyne Geussens, Vincent Grégoire, Bie De Ost, Pol Specenier, Kin-Jip Cheung, Dirk Van Gestel, Danielle Van den Weyngaert, Olivier M. Vanderveken, Kristien Wouters
المصدر: The oncologist
مصطلحات موضوعية: Larynx, Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, medicine.medical_treatment, Single Center, Gastroenterology, Tomotherapy, Belgium, Internal medicine, medicine, Humans, Neoplasm Metastasis, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, business.industry, Head and neck cancer, Pharynx, Neoplasms, Second Primary, Radiotherapy Dosage, Middle Aged, medicine.disease, Combined Modality Therapy, Survival Analysis, Radiation therapy, medicine.anatomical_structure, Treatment Outcome, Oncology, Head and Neck Cancers, Head and Neck Neoplasms, Toxicity, Disease Progression, Female, Radiotherapy, Intensity-Modulated, Human medicine, Nuclear medicine, business